Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
about
Sarcopenia and age-related endocrine functionCancer cachexia--pathophysiology and managementMyostatin from the heart: local and systemic actions in cardiac failure and muscle wastingDecreased specific force and power production of muscle fibers from myostatin-deficient mice are associated with a suppression of protein degradationMeeting the meat: delineating the molecular machinery of muscle developmentRegulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glanceRole of Inflammation in Muscle Homeostasis and MyogenesisMyostatin: expanding horizonsThe quasi-parallel lives of satellite cells and atrophying muscleConnecting Myokines and MetabolismDysregulation of skeletal muscle protein metabolism by alcoholThe molecular basis for load-induced skeletal muscle hypertrophyVitamin D signaling in myogenesis: potential for treatment of sarcopeniaCellular and molecular mechanisms of muscle atrophyMetabolic benefits of resistance training and fast glycolytic skeletal muscle.Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?Inflammatory Mechanisms Associated with Skeletal Muscle Sequelae after Stroke: Role of Physical ExerciseMechanisms of metabolic dysfunction in cancer-associated cachexiaGDF11 Increases with Age and Inhibits Skeletal Muscle RegenerationProteotoxicity: an underappreciated pathology in cardiac diseaseLARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophyMyostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wastingBMP signaling controls muscle massThe methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophyPhenotype selection reveals coevolution of muscle glycogen and protein and PTEN as a gate keeper for the accretion of muscle mass in adult female miceAkt deficiency attenuates muscle size and function but not the response to ActRIIB inhibitionGhrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.The salmonid myostatin gene family: a novel model for investigating mechanisms that influence duplicate gene fate.Acute daily psychological stress causes increased atrophic gene expression and myostatin-dependent muscle atrophy.Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells.Structural basis for potency differences between GDF8 and GDF11.Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte DifferentiationMuscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition.Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.L-leucine, beta-hydroxy-beta-methylbutyric acid (HMB) and creatine monohydrate prevent myostatin-induced Akirin-1/Mighty mRNA down-regulation and myotube atrophy.Involvement of microRNAs in the regulation of muscle wasting during catabolic conditions.
P2860
Q21296731-8416F2F7-CDE7-44B2-8257-24AFCE523D77Q24605567-87C3DEBD-F6CD-480A-A594-256DA7F6AAF5Q24609841-C0F7FF5B-28A4-4A8C-B5E6-222E4C2B7BAFQ24632867-7F14615A-E5F5-4E51-8E5D-0ECDCAB09F1FQ26750626-86EC98AB-207A-42CE-B09A-41F0903FCB4CQ26764871-24F7DEAC-9256-4C09-B983-812359FA0F99Q26778322-33652DD7-D336-415E-967C-CC54A381E5CCQ26797484-82AB3025-A63E-4966-8CD3-0765A596B589Q26800207-84A484B4-53D0-4EE9-908F-56B861D28011Q26801402-2C3B1303-8CA3-426E-A000-9E2BDEBD904DQ26826554-90BF53D2-C667-4CFC-97C6-0178F48D489DQ26829477-9C981C4D-E8A3-4379-8E72-5C2D5223F5A6Q26849642-6BC4E1CE-BDD0-4C00-8A34-A42EBF00AD2EQ27012762-F067FC13-9DB7-45A5-AB58-A94CFFE7CABEQ27687459-977F7D5D-5AB9-42B2-9408-EC02042EDF3EQ28068034-82328BD7-A6D2-4DAB-B1C6-E7F470FD58A4Q28076524-381E0D6C-19F0-4926-91CC-A5EABDFFD232Q28076878-E5D531C9-53D8-4570-A210-7B7E128FEF90Q28079213-870C8827-23B4-49B0-A3D4-BB8E7486F116Q28262319-57D7A2FB-F912-40F6-889E-A499568A56A4Q28304890-9AC1C005-24B1-4392-9F52-FB20CEC23D9AQ28512184-97F444D3-D2DE-4460-BED9-AAD8A880B489Q28588473-29BF251F-37AA-4571-9A17-48A88B5D3546Q28592344-337ED95C-6897-43F3-8CA7-0A9C2529AC27Q28592692-AEE3F383-9223-4024-98A4-7D9D6532A8C9Q28727690-5327D973-59DE-4E6F-9A7B-F9C2DB3064D7Q28749276-774CE451-F126-4620-99C9-4AD7B07196FCQ30384810-EA9F46C9-2D69-4698-9F3F-99C497C8F701Q30422021-62879960-D7F5-41D9-A05E-BE44298EC69DQ30496704-83BD8EE3-DF14-4DC0-BFB3-CF583767F6F7Q30837631-DE5397FE-B55D-4A15-B1E9-A500E4E28BA1Q31813087-6180CC2A-F8C5-481C-881B-8FB4997289F3Q33673668-6683EFFB-77CE-4F12-9C86-8D1E911A460CQ33717152-7C435E97-CD74-4310-900D-23AD004A9BCEQ33737527-D3185129-F2AF-4E81-A162-6E7F0CA51B3AQ33869415-64001EE6-D7F6-4489-8F1A-9E899658C77AQ33901722-C5AB33F1-6D75-4CB1-9C1F-DF9925F9201EQ34001370-01F91816-0C21-4450-BA24-72DC1431B7DEQ34052044-94184E57-B99C-4837-A0A9-6DD463073076Q34070340-26584909-BD61-4973-96DB-FF5E32C95626
P2860
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@ast
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en-gb
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@nl
type
label
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@ast
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en-gb
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@nl
prefLabel
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@ast
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en-gb
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@nl
P2093
P921
P3181
P1476
Myostatin reduces Akt/TORC1/p7 ...... fferentiation and myotube size
@en
P2093
Angelika Meyer
Anne Ulrike Trendelenburg
Daisy Rohner
David J Glass
Joseph Boyle
P304
P3181
P356
10.1152/AJPCELL.00105.2009
P407
P577
2009-04-08T00:00:00Z